We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Approves AstraZeneca’s Moventig for Opioid-Induced Constipation
EMA Approves AstraZeneca’s Moventig for Opioid-Induced Constipation
European regulators have approved AstraZeneca and Nektar Therapeutics’ opioid-induced constipation drug Moventig for adults that have not responded to laxatives.